Protocol GS-US-384-1943: A Phase 3, Randomized

Project: Research project

Project Details


Protocol GS-US-384-1943: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
Effective start/end date1/1/1712/31/25


  • Gilead Sciences, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.